Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB06186> ?p ?o ?g. }
Showing items 1 to 19 of
19
with 100 items per page.
- drugbank:DB06186 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06186 label "Ipilimumab [drugbank:DB06186]" assertion.
- drugbank:DB06186 seeAlso DB06186 assertion.
- drugbank:DB06186 seeAlso ipilimumab.html assertion.
- drugbank:DB06186 seeAlso yervoy-drug.htm assertion.
- drugbank:DB06186 identifier "drugbank:DB06186" assertion.
- drugbank:DB06186 description "Ipilimumab, a recombinant human monoclonal antibody (IgG1 kappa immunoglobin), is an antineoplastic agent developed by Bristol-Myers Squibb and Medarex for the treatment of unresectable or metastatic melanoma in adults. Ipilimumab received FDA approved on March 25, 2011." assertion.
- drugbank:DB06186 title "Ipilimumab" assertion.
- drugbank:DB06186 bio2rdf_vocabulary:identifier "DB06186" assertion.
- drugbank:DB06186 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06186 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06186" assertion.
- drugbank:DB06186 bio2rdf_vocabulary:x-identifiers.org DB06186 assertion.
- drugbank:DB06186 drugbank_vocabulary:drugbank-id "DB06186" assertion.
- drugbank:DB06186 drugbank_vocabulary:x-cas cas:477202-00-9 assertion.
- drugbank:DB06186 drugbank_vocabulary:x-ahfs ahfs:10:00 assertion.
- drugbank:DB06186 drugbank_vocabulary:x-atc atc:L01XC11 assertion.
- drugbank:DB06186 drugbank_vocabulary:x-kegg kegg:D04603 assertion.
- drugbank:DB06186 drugbank_vocabulary:x-wikipedia wikipedia:Ipilimumab assertion.
- drugbank:DB06186 drugbank_vocabulary:x-ndc ndc:0003-2327-11 assertion.